[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Fin_Eng_Net Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1538594701305073666.png) Alan Gałecki – Financial-Engineering.net [@Fin_Eng_Net](/creator/twitter/Fin_Eng_Net) on x 2580 followers
Created: 2025-07-24 12:09:39 UTC

Biotechs are known for being graveyards for investors or generating huge returns.

While not every biotech stock turns out to be a binary bet, it's safe to say big moves catch much attention – no matter the direction.

Sarepta Therapeutics is such a case worth to have heard of.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948354890075697277/c:line.svg)

**Related Topics**
[sarepta therapeutics](/topic/sarepta-therapeutics)

[Post Link](https://x.com/Fin_Eng_Net/status/1948354890075697277)